Join Growin Stock Community!

欣大健康4198.TW Overview

TW StockBiotech. & Medical
(No presentation for 4198)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

欣大健康（4198）Overall Performance

欣大健康（4198）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

欣大健康（4198） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

欣大健康（4198）Key Information

欣大健康（4198）Profile

S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.

欣大健康（4198）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.41
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
6.79
PB Ratio
3.42
Price-to-FCF
370.43
METRIC
VALUE
vs. INDUSTRY
Gross Margin
43.79%
Net Margin
-23.66%
Revenue Growth (YoY)
-57.05%
Profit Growth (YoY)
-3.56%
3-Year Revenue Growth
-14.59%
3-Year Profit Growth
1.40%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.41
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
6.79
PB Ratio
3.42
Price-to-FCF
370.43
Gross Margin
43.79%
Net Margin
-23.66%
Revenue Growth (YoY)
-57.05%
Profit Growth (YoY)
-3.56%
3-Year Revenue Growth
-14.59%
3-Year Profit Growth
1.40%
default symbol

4198

欣大健康

40.35D

0.87%

(0.01)

  • When is 4198's latest earnings report released?

    The most recent financial report for 欣大健康 (4198) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4198's short-term business performance and financial health. For the latest updates on 4198's earnings releases, visit this page regularly.

  • What is the operating profit of 4198?

    According to the latest financial report, 欣大健康 (4198) reported an Operating Profit of -12.46M with an Operating Margin of -28.4% this period, representing a growth of 4.53% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4198's revenue growth?

    In the latest financial report, 欣大健康 (4198) announced revenue of 43.86M, with a Year-Over-Year growth rate of -47.13%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4198 have?

    At the end of the period, 欣大健康 (4198) held Total Cash and Cash Equivalents of 115.26M, accounting for 0.31 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4198 go with three margins increasing?

    In the latest report, 欣大健康 (4198) did not achieve the “three margins increasing” benchmark, with a gross margin of 34.85%%, operating margin of -28.4%%, and net margin of -26.98%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4198's profit trajectory and future growth potential.

  • Is 4198's EPS continuing to grow?

    According to the past four quarterly reports, 欣大健康 (4198)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.5. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4198?

    欣大健康 (4198)'s Free Cash Flow (FCF) for the period is -17.73M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 632.02% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.